1. Home
  2. CXDO vs ORMP Comparison

CXDO vs ORMP Comparison

Compare CXDO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$5.93

Market Cap

189.9M

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.78

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
ORMP
Founded
1995
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.9M
170.3M
IPO Year
1999
2010

Fundamental Metrics

Financial Performance
Metric
CXDO
ORMP
Price
$5.93
$4.78
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.20
N/A
AVG Volume (30 Days)
257.0K
194.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
6.51%
EPS Growth
166.67
412.50
EPS
0.05
2.76
Revenue
$68,167,000.00
$2,000,000.00
Revenue This Year
$45.26
N/A
Revenue Next Year
$13.31
N/A
P/E Ratio
$115.80
$1.70
Revenue Growth
12.05
49.25
52 Week Low
$5.54
$2.09
52 Week High
$11.23
$5.47

Technical Indicators

Market Signals
Indicator
CXDO
ORMP
Relative Strength Index (RSI) N/A 49.71
Support Level N/A $3.91
Resistance Level N/A $5.01
Average True Range (ATR) 0.00 0.16
MACD 0.00 -0.04
Stochastic Oscillator 0.00 27.87

Price Performance

Historical Comparison
CXDO
ORMP

About CXDO Crexendo Inc.

Crexendo Inc is a software technology company that provides cloud communication platform software and unified communications as a service (UCaaS) offering, including voice, video, contact center, and managed IT services. The company operates through two segments: Cloud Telecommunications Services and Software Solutions. Its cloud telecommunications segment generates revenue from the provision of broadband Internet services, managed IT services, software license sales, and infrastructure as a service. The software solutions segment derives revenues from three primary sources: software licenses, software maintenance support and professional services. The majority of the company's revenue is derived from the Cloud Telecommunications Services segment.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: